Lantheus Holdings Inc. (NASDAQ:LNTH)’s share price was down 4.9% on Thursday . The stock traded as low as $4.41 and last traded at $4.50, with a volume of 111,409 shares trading hands. The stock had previously closed at $4.73.

Several equities analysts recently weighed in on LNTH shares. Zacks Investment Research lowered Lantheus Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, March 30th. Robert W. Baird restated a “hold” rating on shares of Lantheus Holdings in a research note on Monday, April 11th. Finally, Jefferies Group restated a “buy” rating on shares of Lantheus Holdings in a research note on Wednesday, May 4th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $5.55.

The stock’s market capitalization is $152.17 million. The company has a 50 day moving average of $2.91 and a 200-day moving average of $2.40.

Lantheus Holdings (NASDAQ:LNTH) last announced its earnings results on Tuesday, May 3rd. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.28. The business had revenue of $76.50 million for the quarter, compared to analyst estimates of $72.43 million. Equities research analysts anticipate that Lantheus Holdings Inc. will post $0.35 earnings per share for the current year.

An institutional investor recently raised its position in Lantheus Holdings stock. Numeric Investors LLC raised its stake in Lantheus Holdings Inc. (NASDAQ:LNTH) by 42.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 525,258 shares of the company’s stock after buying an additional 156,084 shares during the period. Numeric Investors LLC owned approximately 1.67% of Lantheus Holdings worth $1,775,000 at the end of the most recent reporting period.

Lantheus Holdings, Inc is a holding company. The Company, through Lantheus Medical Imaging, Inc, develops, manufactures, sells and distributes diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. It operates in two geographical segments: U.S.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.